BioMarin Pharmaceutical D
D
BMRN
65.055
USD
-1.64
(-2.45%)
مغلق
حجم التداول
141,952
الربح لكل سهم
5
العائد الربحي
-
P/E
176
حجم السوق
12,592,940,892
المقالات
العنوان: BioMarin Pharmaceutical
القطاع: الرعاية الصحية
الصناعة: Biotechnology
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.